Response to “Recognition and Treatment of the Catatonic Syndrome”

Fricchione G , Bush G , Fozdar M .Recognition and treatment of the catatonic syndrome.J Intensive Care Med. 1997;12:135-147

2.CaroffSNMannSCKeckPEJr.Specific treatment of the neuroleptic malignant syndrome. Biol Psychiatry (in press)

Caroff SN , Mann SC. .Neuroleptic malignant syndrome.Med Clin N Am. 1993;77:185-202

Mann SC , Caroff SN , Lazarus A. .Pathogenesis of neuroleptic malignant syndrome.Psychiatric Ann. 1991;21:175-180

Sakkas P , Davis JM , Hua J .Pharmacotherapy of neuroleptic malignant syndrome.Psychiatric Ann. 1991;21:157-164

Rosenberg MR , Green M. .Neuroleptic malignant syndrome; review of response to therapy.Arch Intern Med. 1989;149:1927-1931

Shalev A , Hermesh H , Munitz H. .Mortality from neuroleptic malignant syndrome.J Clin Psychiatry. 1989;50:18-25

Yamawaki S , Yano E , Uvchitomi Y. .Analysis of 497 cases of neuroleptic malignant syndrome in Japan.Hiroshima J Anesth. 1990;26:35-44

Rosebush PI , Stewart T , Mazurek MF. .The treatment of neuroleptic malignant syndrome.Are dantrolene and bromocriptine useful adjuncts to supportive care? Br J Psychiatry. 1991;159:709-712